Good top line growth offset by cost inflation
Top line growth was strong (+14%) thanks to the recovery of the antibiotics business (after the impact of COVID lowering demand) and the start of the new injectable facility in Barcelona, which will be fully running in H2. Additionally, Consumer health division delivered a strong 18% growth. Another important factor to take into account is the higher growth outside Spain, with the rest of Europe business growing 30% vs 6% in Spain. EBITDA grew 6% wit ....
26 Jul 2022
Good recovery in sales
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Good recovery in sales
- Published:
26 Jul 2022 -
Author:
Ruiz Francisco FR -
Pages:
7
Good top line growth offset by cost inflation
Top line growth was strong (+14%) thanks to the recovery of the antibiotics business (after the impact of COVID lowering demand) and the start of the new injectable facility in Barcelona, which will be fully running in H2. Additionally, Consumer health division delivered a strong 18% growth. Another important factor to take into account is the higher growth outside Spain, with the rest of Europe business growing 30% vs 6% in Spain. EBITDA grew 6% wit ....